Smoking-induced monocyte dysfunction is reversed by vitamin C supplementation in vivo

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 1, 2007, Pages 120-126

  Stadler, Nadina ^a   Eggermann, Juliane ^b   Vöö, Stefan ^a   Kranz, Andrea ^b   Waltenberger, Johannes ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Antioxidants; Free radicals; Growth factors; Monocyte dysfunction; Smoking

Indexed keywords

ASCORBIC ACID; PHOSPHOTRANSFERASE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN A; ANTIOXIDANT;

ADULT; ARTICLE; CELL DAMAGE; CELL ISOLATION; CELL MIGRATION; CHEMOTAXIS; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; CARDIOVASCULAR DISEASE; CELL MOTION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SMOKING;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; CARDIOVASCULAR DISEASES; CELL MOVEMENT; CHEMOTAXIS; DIETARY SUPPLEMENTS; HUMANS; MALE; MONOCYTES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847651710     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000250614.97896.4c     Document Type: Article

References (42)

1. Nagy J, Demaster EG, Wittmann I, Shultz P, Raij L. Induction of endothelial cell injury by cigarette smoke. Endothelium. 1997;5:251-263.
2. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol. 1999;31:51-60.
3. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998;101:40-50.
4. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001;49:554-560.
5. Babiak A, Schumm AM, Wangler C, Loukas M, Wu J, Dombrowski S, Mattuschek C, Kotzerke J, Dehio C, Waltenberger J. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion. Cardiovasc Res. 2004;61:789-795.
6. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem. 1996;271:17629-17634.
7. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269:26988-26995.
8. Kroll J, Waltenberger J. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem Biophys Res Commun. 1999;265:636-639.
9. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106:1311-1319.
10. Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A. 1998;95:9349-9354.
11. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation. 2000;102:185-190.
12. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Ünal S, Arinc H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999;99:2239-2242.
13. Werner GS, Richartz BM, Heinke S, Ferrari M, Figulla HR. Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J. 2003;24:1134-1142.
14. Denholm EM, Wolber FM. A simple method for the purification of human peripheral blood monocytes. J Immunol Methods. 1991;144:247-251.
15. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993;362:841-844.
16. 131 labelled human growth hormone of high specific activity. Nature. 1962;194:495-496.
17. Devalaraja RM, Nanney LB, Qian Q, Du J, Yu Y, Devalaraja MN, Richmond A. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol. 2000;115:234-244.
18. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837.
19. Shin VY, Liu ES, Koo MW, Wang JY, Matsui H, Cho CH. Cigarette smoke extracts delay wound healing in the stomach: involvement of polyamine synthesis. Exp Biol Med (Maywood). 2002;227:114-124.
20. Ma L, Chow JY, Cho CH. Cigarette smoking delays ulcer healing: role of constitutive nitric oxide synthase in rat stomach. Am J Physiol. 1999;276:G238-G248.
21. Ueng SW, Lee SS, Lin SS, Wang CR, Liu SJ, Tai CL, Shih CH. Hyperbaric oxygen therapy mitigates the adverse effect of cigarette smoking on the bone healing of tibial lengthening: an experimental study on rabbits. J Trauma. 1999;47:752-759.
22. Schmitz MA, Finnegan M, Natarajan R, Champine J. Effect of smoking on tibial shaft fracture healing. Clin Orthop. 1999;365:184-200.
23. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 1996;94:6-9.
24. Winkelmann BR, Boehm BO, Nauck M, Kleist P, Marz W, Verho NK, Ranjith N, Kneissl G. Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease. Curr Med Res Opin. 2001;17:132-141.
25. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T, Munzel T. Tetrahydrobiopterin improves endotheliumdependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res. 2000;86:E36-E41.
26. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med. 1998;3:21-28.
27. Vayssier-Taussat M, Camilli T, Aron Y, Meplan C, Hainaut P, Polla BS, Weksler B. Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am J Physiol Heart Circ Physiol. 2001;280:H1293-H1300.
28. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation. 2002;105:1155-1157.
29. B. Halliwell JG. Free Radicals In Biology And Medicine. Oxford University Press, UK. 1999;Third Edition.
30. Duvall WL. Endothelial dysfunction and antioxidants. Mt Sinai J Med. 2005;72:71-80.
31. Moller P, Viscovich M, Lykkesfeldt J, Loft S, Jensen A, Poulsen HE. Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers. Eur J Nutr. 2004;43:267-274.
32. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989;86:6377-6381.
33. Forman HJ FI. Superoxide dismutase: a comparison of rate constants. Arch Biochem Biophys. 1973;158:396-400.
34. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun. 1993;18:195-199.
35. Scott DA, Poston RN, Wilson RF, Coward PY, Palmer RM. The influence of vitamin C on systemic markers of endothelial and inflammatory cell activation in smokers and non-smokers. Inflamm Res. 2005;54:138-144.
36. Katayama Y, Shige H, Yamamoto A, Hirata F, Yasuda H. Oral vitamin C ameliorates smoking-induced arterial wall stiffness in healthy volunteers. J Atheroscler Thromb. 2004;11:354-357.
37. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673-2678.
38. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation. 1996;93:1488-1492.
39. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Yoshimura M, Ogawa H, Yasue H. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol. 1997;273:H1644-H1650.
40. Fennessy FM, Moneley DS, Wang JH, Kelly CJ, Bouchier-Hayes DJ. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation. 2003;107:410-415.
41. Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability. J Am Coll Cardiol. 2001;38:1320-1327.
42. Bruno RS, Ramakrishnan R, Montine TJ, Bray TM, Traber MG. {alpha}-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status. Am J Clin Nutr. 2005;81:95-103.